A daily dose of 4 IU of human growth hormone sits at the higher end of what clinicians prescribe for adult growth hormone deficiency and well within what many people use off-label for body composition and anti-aging purposes. At this dose, the most reliably documented effects are a reduction in body fat (particularly around the midsection), a modest increase in lean body mass, and improvements in skin thickness and connective tissue. A landmark trial in men over 60 found that six months of GH treatment produced roughly a 14 percent drop in fat mass and a 9 percent gain in lean mass, along with thicker skin and a small bump in spinal bone density.1PubMed. Effects of human growth hormone in men over 60 years old But these numbers come with a lot of fine print, and the reality of daily GH use is more complicated than the headline results suggest.
Fat Loss Is the Most Consistent Effect
If there is one outcome that shows up reliably across GH studies, it is fat reduction, and visceral fat in particular. Visceral adipose tissue, the deep belly fat packed around your organs, responds more dramatically to GH than subcutaneous fat. Research in adults with newly diagnosed GH deficiency found that GH administration primarily reduced visceral fat stores.2PubMed. Body fat distribution and circulating adipsin are related to metabolic risks in adult patients with newly diagnosed growth hormone deficiency and improve after treatment This makes sense given how GH works metabolically: it pushes the body toward using fat for fuel while sparing protein. The trade-off is that GH directly opposes insulin’s effects on glucose handling, increasing free fatty acid availability by pulling fat out of storage.3Endocrine Reviews. Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
At 4 IU per day, most users report visible changes in abdominal leanness within the first two to three months, though the degree of fat loss depends heavily on diet and starting body composition. The insulin-antagonizing effect also means you should expect your fasting blood glucose to creep upward. For someone already hovering near pre-diabetic levels, this is worth monitoring closely. The fat loss is real and measurable, but it is not free: it comes packaged with metabolic shifts that can work against you if left unchecked.
Lean Mass Gains Are Real but Misleading
This is where expectations go wrong most often. People see “increased lean body mass” and assume it means bigger muscles. The older trial that reported a roughly 9 percent lean mass gain did measure a real change on body scans, but lean mass on a DEXA scan includes everything that is not fat or bone: muscle fibers, but also water, connective tissue, and organ mass.1PubMed. Effects of human growth hormone in men over 60 years old A significant chunk of the “lean mass” increase from GH is water retention and collagen deposition rather than actual contractile muscle tissue.
Controlled research has demonstrated this directly. When GH was administered alongside resistance exercise, the rate of collagen synthesis in muscles and tendons increased substantially, but the synthesis of myofibrillar protein, the contractile fibers that generate force and give muscles their size, did not change.4PubMed Central. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis A commentary on this work stated it plainly: GH grows collagen, not muscle.5PubMed Central. Growing collagen, not muscle, with weightlifting and ‘growth’ hormone So while you may gain weight, fill out a bit, and look different in the mirror (partly from water and connective tissue, partly from fat loss), your actual contractile strength gains from GH alone are modest compared to what anabolic steroids produce.
This does not mean the collagen effect is useless. Stronger tendons and more resilient connective tissue are genuinely valuable, especially for people recovering from injuries or dealing with age-related joint deterioration. But if you are expecting 4 IU per day to pack on slabs of muscle, the evidence says otherwise.
Bone Density Takes Longer Than Everything Else
GH has a well-documented biphasic effect on bone. In the first several months of use, it cranks up both bone formation and bone resorption simultaneously. Markers of bone turnover spike quickly, but net bone mineral density may actually dip slightly before it begins climbing. Studies consistently show that it takes two years or more of GH treatment to see meaningful increases in bone density at the hip and spine.6PubMed. The effects of growth hormone on cortical and cancellous bone
In adults with pituitary-related GH deficiency, two years of replacement therapy produced a sustained increase in bone remodeling and a net gain in bone mineral density that was most pronounced in people who started with the lowest bone density.7The Journal of Clinical Endocrinology & Metabolism. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency In men with idiopathic osteoporosis, two years of GH increased lumbar spine density by about 4 percent and total body bone mineral content, and those gains held for at least a year after stopping treatment.8The Journal of Clinical Endocrinology & Metabolism. Two Years of Treatment with Recombinant Human Growth Hormone Increases Bone Mineral Density in Men with Idiopathic Osteoporosis The takeaway is that if bone health is part of your goal, you will not see results on a 3-month cycle. This is a slow-burn outcome that requires extended use.
Tendon and Joint Effects
Separate from its effects on bone and muscle, GH has a direct impact on tendons. Even local injections of GH into tendon areas boosted collagen synthesis in elderly men, mediated through a rise in localized IGF-1 without any change in systemic IGF-1 levels.9PubMed. Local administration of growth hormone stimulates tendon collagen synthesis in elderly men At systemic doses like 4 IU per day, the effect on tendons is broadly similar: more collagen production, thicker and potentially stronger connective tissue. Many users report that nagging joint issues improve over time, though the first few weeks can feel worse due to water retention in and around the joints.
What Happens to Your Thyroid
A less-discussed consequence of GH therapy is its effect on thyroid hormone metabolism. GH stimulates the conversion of the relatively inactive thyroid hormone T4 into the more active form T3, and it does so in a dose-dependent manner. Research in GH-deficient adults showed that increasing GH doses produced significant increases in both total and free T3, along with an increase in resting energy expenditure.10PubMed. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels Similar findings were reported in children with pituitary insufficiency, where GH treatment enhanced the T4-to-T3 conversion pathway.11PubMed. Action of human growth hormone (hGH) on extrathyroidal conversion of thyroxine (T4) to triiodothyronine (T3) in children with hypopituitarism
This has practical implications. If you had borderline low thyroid function before starting GH, the enhanced T4-to-T3 conversion could mask it on standard blood work, because your free T3 looks fine even though your T4 stores are being drawn down. Conversely, if you are already on thyroid medication, GH can shift your effective thyroid status and may require a dose adjustment. Most clinics that manage GH therapy monitor thyroid panels alongside IGF-1 levels for this reason.
Early Side Effects and Water Retention
The first thing most people notice at 4 IU per day is not fat loss or improved skin. It is swelling. Fingers feel tight, ankles puff up, and carpal tunnel symptoms are common. GH increases sodium and water retention in extracellular fluid, which is the same mechanism behind the carpal tunnel syndrome frequently seen in acromegaly, where the median nerve gets compressed by swollen tissue in the wrist.12PubMed Central. Bilateral carpal tunnel syndrome revealing an acromegaly: a case report At 4 IU per day, the water retention is usually manageable and tends to settle after a few weeks as the body adjusts, but some people find it persistent enough to require reducing the dose temporarily.
Joint aches, particularly in the hands and wrists, are another common early complaint. These are closely related to the fluid retention rather than structural damage. Headaches can also occur, especially in the first week. Most of these nuisance side effects track with the dose: 4 IU is more likely to produce them than 2 IU, and splitting the dose (say, 2 IU in the morning and 2 IU before bed) is a strategy some users adopt to smooth out the peaks.
Your Body Pushes Back
Injecting exogenous GH does not simply add to your natural supply. Your pituitary gland senses the elevated GH levels and dials back its own production. In a controlled study, exogenous GH treatment significantly blunted the pituitary’s response to growth-hormone-releasing factor, with the suppression persisting for at least 24 hours after the last injection.13PubMed Central. Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men This feedback loop has been confirmed at the cellular level, where exposure to exogenous GH directly reduces GH secretion from pituitary cells.14PubMed. Exogenous growth hormone inhibits bovine but not murine pituitary growth hormone secretion in vitro: evidence for a direct feedback of growth hormone on the pituitary
What this means practically is that while you are using exogenous GH at 4 IU per day, your natural pulsatile GH secretion is substantially suppressed. When you stop, there will be a period where your own production has not fully recovered and your total GH exposure is lower than it was even before you started. Most users report this as a “flat” feeling in the weeks after discontinuation. The pituitary does recover, but the timeline varies, and there is limited data on exactly how long full recovery takes in healthy adults using supraphysiological doses.
Effects on the Heart
GH deficiency is associated with reduced cardiac mass and impaired heart function, and replacement therapy appears to partially reverse these changes. A meta-analysis of MRI-based studies found that GH replacement in deficient adults increased the left ventricular mass index by about 3.7 grams per square meter of body surface area.15Frontiers in Endocrinology. MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis In animal models of heart failure, short-term GH supplementation improved the heart’s pumping function and reduced wall stress.16PubMed. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure And in a small preliminary trial, GH treatment increased left ventricular wall thickness and reduced chamber size in patients with dilated cardiomyopathy.17PubMed. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
These findings sound promising, but context matters. Most of this research involves people who were clinically deficient or had existing heart disease. In a healthy person using 4 IU per day, the cardiac effects are less clear and could go in either direction: modest improvements in cardiac output and exercise capacity are plausible, but chronically elevated GH and IGF-1 can also promote cardiac hypertrophy that is not benign. Acromegaly, the condition caused by long-term GH excess, carries an increased risk of cardiomyopathy. The dose and duration matter enormously here.
Women Respond Differently Than Men
One of the more underappreciated aspects of GH therapy is how much sex hormones influence the response. Estrogen has a direct antagonistic effect on many of GH’s metabolic actions. In GH-deficient women, oral estrogen suppressed IGF-1 levels and blunted the dose-dependent rise in IGF-1 that GH normally produces, compared with transdermal estrogen, which did not interfere as much.18PubMed. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women This means women taking oral contraceptives or oral hormone replacement therapy effectively need a higher GH dose to achieve the same IGF-1 response as men or as women on transdermal estrogen.19PubMed. Growth hormone and estrogen: a clinician’s approach
In practice, a woman on oral estrogen who injects 4 IU of GH may see notably less fat loss and a smaller rise in IGF-1 than a man at the same dose. This does not mean GH is ineffective for women, but it does mean that dosing needs to account for estrogen status. Clinicians who specialize in this area often titrate based on IGF-1 levels rather than using a fixed dose, partly because of these sex-based differences.
IGF-1 Monitoring and the Plateau Effect
GH exerts most of its downstream effects through IGF-1, which the liver produces in response to GH stimulation. At 4 IU per day, you can expect IGF-1 levels to rise substantially within the first few months. However, the relationship between dose and IGF-1 is not linear, and there appears to be a ceiling. In GH-deficient children, IGF-1 levels rose significantly during the first six months of therapy but did not climb further at twelve months, even after the GH dose was increased.20PubMed. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children? – Section: RESULTS Pushing the dose higher does not always translate to proportionally higher IGF-1, and chasing higher IGF-1 numbers carries its own risks.
Cancer Risk and Elevated IGF-1
This is the question that hangs over long-term GH use. A review summarizing four meta-analyses found that IGF-1 levels in the highest percentiles of the normal range were associated with increased risk for several common cancers, including prostate, colorectal, and breast cancer.21Endocrine Reviews. Growth Hormone’s Links to Cancer The evidence here is epidemiological, meaning it shows association, not proof that elevating IGF-1 with exogenous GH will cause cancer. But it is consistent enough that researchers have flagged it repeatedly. At 4 IU per day, most users will have IGF-1 levels above the midpoint of the reference range, and many will exceed the upper limit. How much risk that adds, and over what timeframe, remains uncertain. The honest answer is that nobody has run a large randomized trial of long-term supraphysiological GH use in healthy adults to see what happens to cancer rates decades later.
Separately, prolonged use at high doses can push someone into a state resembling mild acromegaly, with characteristic bony changes in the jaw, hands, and feet. Case reports have documented acromegalic features developing as a complication of exogenous GH therapy when doses were excessive or poorly monitored.22Endocrine Practice. Acromegaly as a Complication of Growth Hormone Therapy These changes develop slowly and are largely irreversible once established.
When to Inject and How Absorption Works
GH is typically administered as a subcutaneous injection, usually in the abdomen. After a subcutaneous shot, blood levels of GH peak at around two hours.23PubMed. A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency Intramuscular injection produces a higher peak concentration and a larger total exposure than subcutaneous injection at the same dose, though subcutaneous remains the standard route because of convenience and consistency.24European Journal of Endocrinology. Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration
Timing is a common debate. Evening injections more closely mimic the body’s natural pattern of GH secretion, which peaks during early sleep. Research comparing morning and evening GH injections found that both schedules produce comparable effects on growth and IGF-1 levels, but the evening schedule better imitates the natural rhythm.25PubMed Central. Morning vs. evening growth hormone injections and their impact on sleep-wake patterns and daytime alertness That said, evening injections are not without a trade-off.
How GH Affects Sleep
Natural GH secretion is tightly linked to deep sleep, but injecting additional GH does not necessarily improve sleep quality. In adults with GH deficiency, replacement therapy shortened total sleep time compared to placebo, mainly because subjects woke up earlier, and reduced the intensity of slow-wave (deep) sleep.26PubMed Central. Impact of growth hormone replacement therapy on sleep in adult patients with growth hormone deficiency of pituitary origin Similar findings appeared in children with GH deficiency receiving replacement therapy, who showed increased wakefulness and decreased sleep efficiency.27Sleep Medicine. Effects of replacement therapy on sleep architecture in children with growth hormone deficiency
This is counterintuitive: GH is secreted during deep sleep, so you might expect that adding more GH would enhance that phase. Instead, the exogenous supply seems to partially substitute for the signal that drives deep sleep, reducing the body’s need to generate its own nocturnal GH pulse. At 4 IU per day, some users report vivid dreams and more restful-feeling sleep, while others notice they wake up earlier than usual or feel less rested. These effects likely depend on when the injection is taken, individual sleep architecture, and whether the person was GH-deficient to begin with.
Age Changes the Equation
The GH/IGF-1 axis declines naturally with age, which is part of the rationale behind anti-aging GH use. But the aging pituitary also responds less vigorously to stimulation. Research on growth hormone secretagogues has shown that the GH response is significantly stronger in younger subjects than in older ones, even when the same stimulatory compounds are used.28Frontiers in Aging. Growth hormone and aging: a clinical review This means that while an older adult may have more to gain from restoring GH levels, their body is also less efficient at utilizing the hormonal signal. A 60-year-old on 4 IU per day is not getting the same downstream response as a 30-year-old at the same dose, even if their blood levels of GH look similar on paper. Clinicians managing older patients tend to start at lower doses and titrate upward based on IGF-1 response and side effect tolerance, partly because the side effects, particularly glucose elevation and joint issues, tend to be more pronounced in older individuals who already have less metabolic reserve.